Fortress Biotech Inc (FBIO) - Financial and Strategic SWOT Analysis Review

  • ID: 4282010
  • SWOT Analysis
  • 48 pages
  • GlobalData
1 of 5

FEATURED COMPANIES

  • Argos Therapeutics Inc
  • Exicure Inc
  • Novus Therapeutics Inc
  • MORE
Fortress Biotech Inc (FBIO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Fortress Biotech Inc (Fortress), formerly Coronado Biosciences Inc is a biopharmaceutical company that develops and commercializes pharmaceutical and biotechnology products. The company offers products in the areas of dermatology, cancer, pain management and autoimmune diseases, among others. It offers Dermasorb HC, Luxamed wound cream and Ceracade. Fortress's products are used to treat and manage atopic dermatitis, wounds and other dermatological diseases. The company also provides funding to support their research and development programs. It markets its products in the US and abroad. Fortress is headquartered in New York, the US.

Fortress Biotech Inc Key Recent Developments

Nov 09, 2017: Fortress Biotech Reports Third Quarter 2017 Financial Results and Recent Corporate Highlights
Oct 30, 2017: Mustang Bio Establishes CAR T Cell Therapy Manufacturing Facility in Massachusetts
Aug 14, 2017: Fortress Biotech Forms New Subsidiary, Aevitas Therapeutics, to Develop Novel AAV Gene Therapy Treatments for Complement-Mediated Diseases
Aug 14, 2017: Mustang Bio Reports Second Quarter 2017 Financial Results and Recent Corporate Highlights
Aug 09, 2017: Fortress Biotech Reports Second Quarter 2017 Financial Results and Recent Corporate Highlights

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Argos Therapeutics Inc
  • Exicure Inc
  • Novus Therapeutics Inc
  • MORE
Section 1 - About the Company
  • Fortress Biotech Inc - Key Facts
  • Fortress Biotech Inc - Key Employees
  • Fortress Biotech Inc - Major Products and Services
  • Fortress Biotech Inc - History
  • Fortress Biotech Inc - Company Statement
  • Fortress Biotech Inc - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
  • Joint Venture
Section 2 - Company Analysis
  • Company Overview
  • Fortress Biotech Inc - Business Description
  • R&D Overview
  • Fortress Biotech Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • Fortress Biotech Inc - Strengths
  • Fortress Biotech Inc - Weaknesses
  • Fortress Biotech Inc - Opportunities
  • Fortress Biotech Inc - Threats
  • Fortress Biotech Inc - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • Fortress Biotech Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
  • Fortress Biotech Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
  • Fortress Biotech Inc, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • Nov 09, 2017: Fortress Biotech Reports Third Quarter 2017 Financial Results and Recent Corporate Highlights
  • Oct 30, 2017: Mustang Bio Establishes CAR T Cell Therapy Manufacturing Facility in Massachusetts
  • Aug 14, 2017: Fortress Biotech Forms New Subsidiary, Aevitas Therapeutics, to Develop Novel AAV Gene Therapy Treatments for Complement-Mediated Diseases
  • Aug 14, 2017: Mustang Bio Reports Second Quarter 2017 Financial Results and Recent Corporate Highlights
  • Aug 09, 2017: Fortress Biotech Reports Second Quarter 2017 Financial Results and Recent Corporate Highlights
  • Jul 03, 2017: Fortress Biotech Announces Appointment of Lucy Lu, MD, as President and Chief Executive Officer of Subsidiary Avenue Therapeutics
  • Jul 03, 2017: Fortress Biotech names president and CEO of Avenue Therapeutics
  • May 10, 2017: Fortress Biotech Reports First Quarter 2017 Financial Results and Recent Corporate Highlights
  • Mar 16, 2017: Fortress Biotech Reports Financial Results for the Fourth Quarter and Full Year Ended December 31, 2016
  • Mar 14, 2017: Fortress Biotech Forms New Subsidiary, Cyprium Therapeutics to Develop Novel Therapies for Menkes Disease and Related Copper Metabolism Disorders
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About
  • Contact
  • Disclaimer
List of Tables
  • Fortress Biotech Inc, Key Facts
  • Fortress Biotech Inc, Key Employees
  • Fortress Biotech Inc, Major Products and Services
  • Fortress Biotech Inc, History
  • Fortress Biotech Inc, Other Locations
  • Fortress Biotech Inc, Subsidiaries
  • Fortress Biotech Inc, Joint Venture
  • Fortress Biotech Inc, Key Competitors
  • Fortress Biotech Inc, Ratios based on current share price
  • Fortress Biotech Inc, Annual Ratios
  • Fortress Biotech Inc, Annual Ratios (Cont...1)
  • Fortress Biotech Inc, Interim Ratios
  • Fortress Biotech Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
  • Fortress Biotech Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
  • Fortress Biotech Inc, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Fortress Biotech Inc, Performance Chart (2012 - 2016)
  • Fortress Biotech Inc, Ratio Charts
  • Fortress Biotech Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
  • Fortress Biotech Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • Novus Therapeutics Inc
  • Five Prime Therapeutics Inc
  • Exicure Inc
  • Argos Therapeutics Inc
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll